Will Herrington
@willkidney
Followers
2K
Following
1K
Media
63
Statuses
634
Prof@Oxford_NDPH, Hon.Nephrologist, EMPA-KIDNEY & EASi-KIDNEY CI. Join the fight against CKD, systematic bias & random error: make studies larger & randomized!
Oxford, England
Joined April 2016
AAM of #EASi-KIDNEY rationale paper now available @NDTsocial š recruitment started in 3 countries already!.
Now open access in @NDTsocial. The potential for improving cardio-renal outcomes in CKD with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial . ā¶ļø
1
5
25
We donāt want travel insurance companies to punish trial volunteers - the treatments we all rely upon are thanks to volunteers from the past, present and future. Worth everyone subsiding. Agreed? If so, please sign belowā¦.!
petition.parliament.uk
Ban travel insurance companies vastly increasing premiums, or refusal to cover people who partake in clinical trials, which may make it impossible for them to travel without resulting in substantial...
0
0
4
RT @Oxford_NDPH: #EASIKIDNEY is an international randomised trial aiming to recruit 11,000 patients living with #chronickidneydisease, demoā¦.
0
2
0
RT @cellotonelli: Kidney disease affects 850M people and is projected to be the 5th leading cause of death by 2050, yet itās absent from thā¦.
0
20
0
RT @mvaduganathan: #ACHIEVE largest CVOT (n=2538) of spiro in dialysis neutral CV benefit #ERA25. sMRA in CKM:.RALES ā
.EPHESUS ā
.EMPHASIS ā
ā¦.
0
28
0
RT @DrDanMO: How they predicted eGFR dips. Stop rate by week 12 was very low in the 4 trialsā data they used, and not much relationship toā¦.
0
1
0
0
2
0
Vienna is calling - these #ERA25 stickers will quickly become fridge magnets!.
Waiting for you in Vienna! š¦š¹#ERA25 is ready š Safe travels to everyone āļøšš@ERAkidney
2
0
19
0
39
0
RT @ISNkidneycare: š Together, we made history for kidney health! . For the first time ever, kidney care is officially on the global healthā¦.
0
118
0
RT @Kidney_Research: We had the amazing opportunity to bring kidney disease into the spotlight with Wes Streeting, Secretary of State for Hā¦.
0
6
0
RT @AKronbichler: In case you missed our Journal Club (@ERAkidney) yesterday. The proposal of DMAND definition was presented by @LuvacsL yeā¦.
0
5
0
RT @KSusztak: Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease | ā¦@NEJMā©
nejm.org
In the EMPA-KIDNEY trial, empagliflozin, a sodiumāglucose cotransporter 2 (SGLT2) inhibitor, had positive cardiorenal effects in patients with chronic kidney disease who were at risk for disease pr...
0
8
0
RT @kamleshkhunti: Great to see post trial follow-up of a CVOT!. EMPAKIDNEY . Empagliflozin continued to have additional cardiorenal benefiā¦.
0
38
0
If you havenāt heard why Oxford Renal Studies Grp believe innovations in conduct of trials r more important than developing surrogates & new analytic methods then this is your bedtime read 4 tonight!!! Not exhilarating, until you see the magic of examples.
academic.oup.com
PLAIN ENGLISH SUMMARYā. In the last 5ā10 years, several large high-quality research trials testing new treatments versus a dummy treatment in patients with
0
12
38
RT @asnpublications: Editorsā Choice 2024: Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozinā¦.
0
20
0
RT @NEJM: Our latest video in our partnership with @DGlaucomflecken explains the results of the RESHAPE-HF2 trial investigating whether traā¦.
0
133
0
RT @radcliffeCARDIO: Prof @willkidney discusses the EMPA-KIDNEY trial on long-term effects of #empagliflozin in patients with #CKD. š½ļøWatā¦.
0
5
0
RT @SreejithDr: @kidney_boy & @NephRodby killing it on stage as 'Sherlock Holmes' & 'John Watson' (by turn) at the ApEx Pathsala, Mumbai, tā¦.
0
10
0